<qa>  What is the pathologic response in patients with resectable esophageal- Evaluate the pathologic response complete and partial in patients with resectable esophageal or gastroesophageal junction cancer treated with neoadjuvant gefitinib, cisplatin, irinotecan hydrochloride, and radiotherapy followed by surgical resection. 